Zdravlje is pleased to announce that as of 1st September 2022, Mr. Tsvetomir Yordanov has joined our senior management team as Group Business Development Director, directly reporting to Kiren Naidoo (CEO).

Tsvetomir graduated in International Business and holds a master’s degree in Public Finance from the UNWE (Economics University), Sofia, Bulgaria.

Tsvetomir joined Zdravlje bringing his rich professional experiences of a Senior Business Development Manager at the Zentiva and Alvogen, two leading and high-growth multinational pharmaceutical companies. Prior to that, for more than 6 years, he held the roles of Corporate In-licensing Manager and later Associate Director In-Licensing at Actavis/Teva.

We are confident that the professional experience gained at these positions and companies will support Zdravlje’s further expansion locally and internationally. Tsvetomir will be based across Sofia, Belgrade & Leskovac and will lead new business initiatives to support the growth of our Manufacturing (CDMO), Commercial and Strategic Project business units.

Commenting on his joining Zdravlje Team, Tsvetomir shared his enthusiasm: “I am very excited to join the young and ambitious Zdravlje team on the exciting journey ahead – the journey to bring state-of-the-art and affordable therapies to patients in need in our home market and beyond”.

“We are pleased to welcome Tsvetomir to our team. I am confident that his business development expertise and valuable experience will add substantial value to our company.” said Kiren Naidoo, CEO of Zdravlje.

We welcome Tsvetomir to the team and wish him all the best in his new role at Zdravlje.